Amiodarone for Atrial Fibrillation
(RADICAL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how different dosing schedules of amiodarone, a medication for irregular heartbeats, work for patients who develop atrial fibrillation after non-emergency heart surgery. The study compares two methods: one with repeated doses when the heart rate increases and another with a conventional dosing schedule. It seeks participants planning to undergo heart surgery, such as a bypass or valve repair, who have not experienced previous irregular heartbeats or certain heart procedures. As a Phase 4 trial, this research aims to understand how this FDA-approved and effective treatment can benefit more patients.
Do I have to stop taking my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for amiodarone?
Studies have shown that amiodarone is generally well-tolerated, even in large doses. Research indicates that a 150 mg dose administered directly into a vein (IV) is safe, but higher daily doses can increase the risk of side effects like low blood pressure.
For repeated doses, additional 150 mg IV doses are sometimes used to manage fast heart rates, and available data considers these safe. However, larger doses can raise the risk of side effects.
In the usual treatment plan, similar safety findings apply. This plan typically starts with a 150 mg IV dose, followed by a continuous drip. This approach aims to control heart rhythms effectively while maintaining safety. Both dosing methods have been studied, and while generally safe, healthcare providers must closely monitor for any potential side effects.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about the repeated amiodarone dosing regimen (RBDR) because it offers a proactive way to manage tachycardia during cardiac surgeries. Unlike conventional dosing, which follows a set schedule, the RBDR allows for additional amiodarone boluses whenever a patient's heart rate spikes above 110 beats per minute for more than 10 minutes. This approach aims to provide more immediate control over heart rate fluctuations, potentially improving patient outcomes in a high-stakes surgical setting.
What evidence suggests that this trial's treatments could be effective for atrial fibrillation after cardiac surgery?
Research has shown that amiodarone helps control irregular heartbeats after heart surgery. One study found that 72% of patients with frequent irregular heartbeats experienced complete cessation of these episodes with amiodarone. In this trial, participants will receive one of two dosing regimens. The conventional dosing regimen effectively controls and maintains a normal heart rate. The repeated bolus dosing regimen, which involves administering extra doses when the heart rate spikes, might offer additional benefits. Both methods aim to reach a total of 8 grams of amiodarone, and studies suggest they are equally effective in managing heart rate issues after surgery.13678
Who Is on the Research Team?
Kevin Hatton, MD
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a conventional or repeated amiodarone dosing regimen to manage postoperative atrial fibrillation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including heart rate and rhythm stability
Long-term follow-up
Participants are monitored for recurrent atrial fibrillation and maintenance of normal sinus rhythm until hospital discharge
What Are the Treatments Tested in This Trial?
Interventions
- Amiodarone
How Is the Trial Designed?
2
Treatment groups
Active Control
Initial amiodarone bolus of 150 mg IV over 10 minutes, then 1.0 mg/min IV amiodarone infusion for 6 hours, then a 0.5 mg/min IV amiodarone infusion for 18 hours, followed by enteral (400 mg amiodarone oral or per tube three times daily or 2 times daily if the patient has gastrointestinal intolerance when taking the drug three times daily) or intravenous amiodarone (0.5 mg/min continuous infusion) to complete an 8-gm total amiodarone load. In addition, patients in the RBDR will receive an additional 150 mg IV amiodarone bolus whenever the patient develops tachycardia (Heart Rate (HR) = 110 beats per minute) lasting more than 10 minutes. This bolus may be repeated up to a total of 5 times (6 total boluses) over the first 24 hours. Maintenance amiodarone (200 mg amiodarone oral or per tube once daily) at discretion of attending physician.
Initial amiodarone bolus of 150 mg IV over 10 minutes then a 24-hour amiodarone loading infusion (1 mg/min for 6 hours followed by 0.5 mg/min for 18 hours), followed by enteral (400 mg amiodarone oral or per tube three times daily or 2 times daily if the patient has gastrointestinal intolerance when taking the drug three times daily) or intravenous amiodarone (0.5 mg/min continuous infusion) to complete an 8-gm total amiodarone load. Maintenance amiodarone (200 mg amiodarone oral or per tube once daily) at discretion of attending physician.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kevin W Hatton, MD, PhD
Lead Sponsor
Kevin Hatton
Lead Sponsor
Citations
Prospective, randomized comparison of conventional and ...
The therapeutic and electrophysiologic effects of conventional and high dose loading regimens of amiodarone do not differ significantly after 3 or 10 days ...
Prospective, randomized comparison of conventional and ...
After 10 days of therapy, four patients in each group had an adequate response to amiodarone (p = NS). Three patients who received the high dose and one patient ...
Evidence-Based Analysis of Amiodarone Efficacy and Safety
For low-dose amiodarone, high-dose amiodarone, and bretylium, these rates were 1.68, 0.48, and 0.96 events per 24 hours, respectively (P=0.237). There was no ...
Amiodarone - StatPearls - NCBI Bookshelf - NIH
Amiodarone has demonstrated effective control of the ventricular rate and successful conversion to and maintenance of sinus rhythm in ...
5.
sciencedirect.com
sciencedirect.com/science/article/pii/073510979390603X/pdf?md5=a41e485557bff43248ce9880bc43b9e1&pid=1-s2.0-073510979390603X-main.pdfJACC Vol. 22, No. 6
The two dosing regimens we tested resulted in significant prolonga- tion of the sinus cycle length, ventricular effective refractory period and AV block cycle ...
Amiodarone Dosage Guide + Max Dose, Adjustments
Detailed Amiodarone dosage information for adults. Includes dosages for Arrhythmias; plus renal, liver and dialysis adjustments.
Amiodarone HCl injection for intravenous use
Pediatric use: The safety and efficacy of amiodarone in the pediatric rates of infusion provided in DOSAGE AND ADMINISTRATION (2)reflect dosing in.
Amiodarone: uses, dosing, warnings, adverse events, ...
In one study, the time to first episode of ventricular tachycardia or ventricular fibrillation was approximately 10 or 14 hours in patients receiving the 125- ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.